Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
about
Targeted therapies in sarcomas: challenging the challengeSmall is beautiful: insulin-like growth factors and their role in growth, development, and cancerEpigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1.FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer.Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and ExpectationsPrognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1.RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas.PDGF receptor alpha is an alternative mediator of rapamycin-induced Akt activation: implications for combination targeted therapy of synovial sarcomaMolecular profiling of childhood cancer: Biomarkers and novel therapiesTissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcomaTargeting protein kinases to reverse multidrug resistance in sarcoma.Of mice and men: opportunities to use genetically engineered mouse models of synovial sarcoma for preclinical cancer therapeutic evaluationInflammatory stress and sarcomagenesis: a vicious interplay.Type I insulin-like growth factor receptor signaling in hematological malignancies.Past, present and future of therapies in pediatric sarcomas.Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities.The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer.SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.Evaluation of the expression and role of IGF pathway biomarkers in human sarcomas.A novel multi-kinase inhibitor pazopanib suppresses growth of synovial sarcoma cells through inhibition of the PI3K-AKT pathway.Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcoma.Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.The emerging role of insulin-like growth factor 1 receptor (IGF1r) in gastrointestinal stromal tumors (GISTs).Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy.Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.Expression of insulin-like growth factor 2 in mesenchymal neoplasms.Targeted therapy of soft tissue sarcomas.
P2860
Q21285014-86BCD55F-4AFF-4FD5-9D3D-84A49FBA978AQ30395770-D4B727D1-C5A6-4520-9ECE-A3C7A19B9127Q30914150-3DB0C98C-588E-4A72-8270-C207239ACADFQ34206722-FA05F6BA-BD08-4B3D-B38C-C44F71C7EA0FQ35013284-C1B7F2CF-8CFD-4115-98AE-F2D8D6437D5FQ35061368-617B2C79-6ABB-4DE8-9558-A5C661744845Q35200425-13CC5525-4728-4D42-81ED-6CD5B31CE3E9Q36088188-F27F7198-0C99-4E8A-AD8F-D3CB88040FBFQ36204986-58DD5720-B068-4B67-BDC4-06B815E65D49Q36250783-D39966F8-2A35-4092-80DB-B35F8AA873F3Q36420180-99789E29-5DDB-4B99-AD8A-C004F3691FF2Q36527950-C026784E-EF69-45C6-9A95-7C04575D0305Q37222595-6A105936-1DE4-4239-975B-63B7EB562A73Q37378867-795A26CB-70F6-4DAC-83E7-A016449A093BQ37702186-5C12629A-D332-4CC9-86E2-ED8821F8EBFFQ37725915-BA8DD927-82D2-4639-8800-18ADC130088BQ38006606-C49F8B9F-128E-46F5-8743-FF7857678B05Q38097400-B1AC4EF5-A348-4688-806F-98F4E3AC0E29Q39069350-2C2C65B2-BFB9-437D-BCE7-BB5D6140C556Q39175962-6D9BB6C7-2C27-4DB8-B275-087A98000030Q39391651-B1531B71-D0AC-41E9-BBAF-735E64DBF6E3Q39624408-346C7091-917F-4361-9B86-1B655D47DCA7Q39753305-E53C92F9-0F00-4DF5-9EA1-62AD8256E98AQ39817075-A5D0B9A5-46DA-4CCE-8E61-2A89182674E2Q41918438-FF03B070-5906-42A0-B869-8B4CA85F00FEQ43144913-66C3FFF7-BB38-4BE6-9D53-795D80531C0EQ43887658-03A73450-C1D5-4595-87A1-D113DDE56078Q54533332-CB947DE0-2ADA-4063-B09E-B2CB2ECC1A87
P2860
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
@en
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
@nl
type
label
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
@en
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
@nl
prefLabel
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
@en
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
@nl
P2093
P2860
P356
P1476
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma
@en
P2093
E Wardelmann
J Czerwitzki
J H Schulte
N Friedrichs
P2860
P304
P356
10.1002/PATH.2438
P577
2008-12-01T00:00:00Z